Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 16:44:39 19/07/2024 BST 5-day change 1st Jan Change
149.6 EUR -1.93% Intraday chart for Merck KGaA -3.01% +3.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MERCK : Q2 cost absorption and the most recent cool development Alphavalue
German Stocks in Red as ECB Delivers Rate Hold MT
MERCK KGAA : Gets a Buy rating from Jefferies ZD
Merck KGaA to Buy French Semiconductor Metrology Group Unity-SC MT
JPMorgan rates Merck KGaA at 'Overweight' - Target 190 euros DP
Germany's Merck to Buy Unity-SC for at Least $170 Million DJ
MERCK KGAA : JP Morgan reaffirms its Buy rating ZD
Merck acquires French company Unity-SC for 155 million euros RE
MERCK KGAA : Receives a Buy rating from Jefferies ZD
Merck KGaA: share price down, analyst lowers target CF
MERCK KGAA : UBS lowers price target CF
UBS lowers target for Merck KGaA to 178 euros - 'Buy' DP
MERCK KGAA : UBS keeps its Buy rating ZD
Dawn Health and Merck Collaborate to Support Growth Disorders Care CI
Chemicals collective agreement: Bonus days for union members DP
Chemicals collective bargaining agreement: extra day for trade unionists DP
Chemical industry wage partners seek solution before the end of the peace period DP
German Stocks Fall Tuesday DJ
Market Update-Europe closes lower in a session marked by a wait-and-see attitude RE
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla... Our Logo
MERCK KGAA : Barclays cuts its target price CF
MERCK KGAA : Gets a Neutral rating from Bernstein ZD
MERCK KGAA : failure in head and neck cancer trial CF
UBS reiterates Merck KGaA at 'Buy' - Target 186 euros DP
Next pharmaceutical study flop for Merck KGaA - share price collapses DP
Chart Merck KGaA
More charts
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
149.6 EUR
Average target price
181.4 EUR
Spread / Average Target
+21.28%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck KGaA Completes EUR180 Million German Distribution Center Expansion